These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38866726)

  • 1. Enhancing PDT efficacy in NMIBC: Efflux inhibitor mediated improvement of PpIX levels and efficacy of the combination of PpIX-PDT and SO-cleavable prodrugs.
    Kumbham S; Rahman KMM; Bosmajian C; Bist G; Foster BA; Woo S; You Y
    Photochem Photobiol; 2024; 100(6):1636-1646. PubMed ID: 38866726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of singlet oxygen-cleavable prodrugs in combination with protoporphyrin IX-photodynamic therapy in an orthotopic rat model of non-muscle-invasive bladder cancer.
    Rahman KMM; Foster BA; You Y
    Photochem Photobiol; 2024; 100(6):1590-1602. PubMed ID: 37469327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of red and green light for treating non-muscle invasive bladder cancer in rats using singlet oxygen-cleavable prodrugs with PPIX-PDT.
    Rahman KMM; Kumbham S; Bist G; Woo S; Foster BA; You Y
    Photochem Photobiol; 2024; 100(6):1659-1675. PubMed ID: 38533776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial targeting improves the selectivity of singlet-oxygen cleavable prodrugs in NMIBC treatment.
    Rahman KMM; Bist G; Kumbham S; Foster BA; Woo S; You Y
    Photochem Photobiol; 2024; 100(6):1622-1635. PubMed ID: 38433310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of lapatinib for enhancing 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy in human cancer cell lines with varied ABCG2 activities.
    Howley R; Olsen J; Chen B
    Photochem Photobiol; 2024; 100(6):1579-1589. PubMed ID: 38477138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
    Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
    J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
    Mansi M; Howley R; Chandratre S; Chen B
    Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminolevulinic acid-mediated photodynamic therapy in combination with kinase inhibitor lapatinib enhances glioblastoma cell death.
    Chandratre S; Merenich D; Myers K; Chen B
    Apoptosis; 2024 Dec; 29(11-12):1978-1987. PubMed ID: 39190205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
    Magnussen A; Reburn C; Perry A; Wood M; Curnow A
    Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic Therapy for Bladder Cancers, A Focused Review
    Rahman KMM; Giram P; Foster BA; You Y
    Photochem Photobiol; 2023 Mar; 99(2):420-436. PubMed ID: 36138552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
    Curnow A; Perry A; Wood M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
    Schary N; Novak B; Kämper L; Yousf A; Lübbert H
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
    Howley R; Mansi M; Shinde J; Restrepo J; Chen B
    J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
    Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
    Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.
    Zhang J; Yuan S; Fan M; Wang K; Guo J; Zang A; Ren J; Su W; Zhang C; Xie Y
    Bioorg Med Chem; 2024 May; 105():117726. PubMed ID: 38626642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
    Anayo L; Magnussen A; Perry A; Wood M; Curnow A
    Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate.
    Berrahmoune S; Fotinos N; Bezdetnaya L; Lange N; Guedenet JC; Guillemin F; D'Hallewin MA
    Photochem Photobiol Sci; 2008 Sep; 7(9):1018-24. PubMed ID: 18754047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
    Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
    Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
    Chandratre S; Olsen J; Howley R; Chen B
    Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.